The ventrolateral medulla and medullary raphe in sudden unexpected death in epilepsy by Patodia, S. et al.
The ventrolateral medulla and medullary raphe
in sudden unexpected death in epilepsy
Smriti Patodia,1,2 Alyma Somani,1,2 Megan O’Hare,2,* Ranjana Venkateswaran,1,2,*
Joan Liu,1,2,3 Zuzanna Michalak,1,2 Matthew Ellis,1 Ingrid E. Scheffer,4 Beate Diehl,2
Sanjay M. Sisodiya2 and Maria Thom1,2
*These authors contributed equally to this work.
Sudden unexpected death in epilepsy (SUDEP) is a leading cause of premature death in patients with epilepsy. One hypothesis
proposes that sudden death is mediated by post-ictal central respiratory depression, which could relate to underlying pathology in
key respiratory nuclei and/or their neuromodulators. Our aim was to investigate neuronal populations in the ventrolateral medulla
(which includes the putative human pre-Bo¨tzinger complex) and the medullary raphe. Forty brainstems were studied comprising
four groups: 14 SUDEP, six epilepsy controls, seven Dravet syndrome cases and 13 non-epilepsy controls. Serial sections through
the medulla (from obex 1 to 10mm) were stained for Nissl, somatostatin, neurokinin 1 receptor (for pre-Bo¨tzinger complex
neurons) and galanin, tryptophan hydroxylase and serotonin transporter (neuromodulatory systems). Using stereology total neur-
onal number and densities, with respect to obex level, were measured. Whole slide scanning image analysis was used to quantify
immunolabelling indices as well as co-localization between markers. Signiﬁcant ﬁndings included reduction in somatostatin neurons
and neurokinin 1 receptor labelling in the ventrolateral medulla in sudden death in epilepsy compared to controls (P5 0.05).
Galanin and tryptophan hydroxylase labelling was also reduced in sudden death cases and more signiﬁcantly in the ventrolateral
medulla region than the raphe (P50.005 and P5 0.05). With serotonin transporter, reduction in labelling in cases of sudden
death in epilepsy was noted only in the raphe (P40.01); however, co-localization with tryptophan hydroxylase was signiﬁcantly
reduced in the ventrolateral medulla. Epilepsy controls and cases with Dravet syndrome showed less signiﬁcant alterations with
differences from non-epilepsy controls noted only for somatostatin in the ventrolateral medulla (P5 0.05). Variations in labelling
with respect to obex level were noted of potential relevance to the rostro-caudal organization of respiratory nuclear groups,
including tryptophan hydroxylase, where the greatest statistical difference noted between all epilepsy cases and controls was at
obex 9–10mm (P = 0.034), the putative level of the pre-Bo¨tzinger complex. Furthermore, there was evidence for variation with
duration of epilepsy for somatostatin and neurokinin 1 receptor. Our ﬁndings suggest alteration to neuronal populations in the
medulla in SUDEP with evidence for greater reduction in neuromodulatory neuropeptidergic and mono-aminergic systems, includ-
ing for galanin, and serotonin. Other nuclei need to be investigated to evaluate if this is part of more widespread brainstem
pathology. Our ﬁndings could be a result of previous seizures and may represent a pathological risk factor for SUDEP through
impaired respiratory homeostasis during a seizure.
1 Departments of Neuropathology, UCL, Institute of Neurology, Queen Square, London WC1N 3BG, UK
2 Clinical and Experimental Epilepsy and Chalfont Centre for Epilepsy, UCL, Institute of Neurology, Queen Square, London WC1N
3BG, UK
3 Department of Biomedical Sciences, University of Westminster London W1W 6UW, UK
4 Epilepsy Research Centre, Department of Medicine (Neurology), University of Melbourne, Victoria 3052, Australia
doi:10.1093/brain/awy078 BRAIN 2018: 141; 1719–1733 | 1719
Received October 23, 2017. Revised January 29, 2018. Accepted February 1, 2018. Advance Access publication March 28, 2018
 The Author(s) (2018). Published by Oxford University Press on behalf of the Guarantors of Brain.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse,
distribution, and reproduction in any medium, provided the original work is properly cited.
D
ow
nloaded from
 https://academ
ic.oup.com
/brain/article-abstract/141/6/1719/4955842 by guest on 06 Septem
ber 2019
Correspondence to: Maria Thom
Department of Neuropathology
UCL, Institute of Neurology
Queen Square
London WC1N 3BG
UK
E-mail: M.Thom@ucl.ac.uk
Keywords: SUDEP; brainstem; pre-Bo¨tzinger complex; medullary raphe; stereology
Abbreviations: pre-Bo¨tC = pre-Bo¨tzinger complex; SERT/5HTT = serotonin transporter; SIDS = sudden infant death syndrome;
SUDEP = sudden and unexpected death in epilepsy; VLM = ventrolateral medulla
Introduction
Sudden and unexpected death in epilepsy (SUDEP) is the
leading cause of death in young adults with intractable
epilepsy (Dlouhy et al., 2016). Ictal respiratory dysfunction
occurs in a subset of patients with epilepsy (Kennedy and
Seyal, 2015) and has been observed as a terminal event in
witnessed SUDEP cases on epilepsy monitoring units
(Ryvlin et al., 2013). There is accumulating evidence from
clinical and experimental models that a centrally mediated
apnoea could underlie some SUDEP cases (Sowers et al.,
2013; Dlouhy et al., 2016).
Central control of respiration is through interconnected
medullary nuclear groups forming the ventral respiratory
column (Smith et al., 2013) in the ventrolateral medulla
(VLM). Largely based on ﬁndings in animal studies, these
nuclei include the pre-Bo¨tzinger complex (pre-Bo¨tC), an es-
sential generator of inspiratory rhythm (McKay et al., 2005;
Feldman and Del Negro, 2006), comprising diverse neuronal
cell types, including pacemaker-like somatostatin (SST) and
neurokinin 1 receptor (NK1R)-positive cells, as well as glyci-
nergic and GABAergic interneurons (Stornetta et al., 2003;
Ramirez-Jarquin et al., 2012; Wei et al., 2012). The pre-Bo¨tC
is further modulated to regulate respiratory rhythm in re-
sponse to physiological and metabolic demands and during
sleep-wake cycles via higher cortical and other brainstem
nuclei (Ramirez et al., 2012; Smith et al., 2013). The latter
are regulated by peripheral and sensory inputs and chemo-
receptors and, through the serotonergic neurons of the me-
dullary raphe, provide excitatory drive in response to
hypoxia and hypercarbia (Richerson, 2004; Benarroch,
2014). Emerging data from clinical and experimental studies
implicate defective serotonergic systems in the respiratory
dysfunction and impaired arousal following seizures that
could be relevant to SUDEP (Richerson, 2013; Sowers
et al., 2013; Zhan et al., 2016). In sudden infant death syn-
drome (SIDS), which has clinical parallels with SUDEP, alter-
ations to medullary serotonergic neuronal populations have
been shown (Paterson et al., 2006; Kinney et al., 2009).
In an MRI study of SUDEP, observed volume loss in the
medulla was proposed to be secondary to sustained seiz-
ure propagation in this region and relevant to ictal auto-
nomic disturbances in SUDEP (Mueller et al., 2014).
Spreading depolarizations in the dorsal medulla
following seizures mediate cardio-respiratory arrest in
mouse SUDEP models (Aiba and Noebels, 2015). Previous
post-mortem studies in neurodegenerative conditions such as
multiple system atrophy and Parkinson’s disease, with asso-
ciated sleep-related respiratory disorders and sudden death,
show pathology in both the pre-Bo¨tC and the medullary
raphe (Tada et al., 2009; Schwarzacher et al., 2011; Presti
et al., 2014), but these regions remain unexplored in SUDEP.
We hypothesized that pathological changes in brainstem
respiratory nuclei could occur in SUDEP and our aim was
to study the VLM region, which encloses the putative
human homologue of the pre-Bo¨tC nucleus (Tada et al.,
2009; Schwarzacher et al., 2011; Presti et al., 2014) and
medullary raphe in a series of SUDEP post-mortem cases
compared with control groups.
Materials and methods
Case selection
Brainstems from 40 post-mortem cases were included in this
study. Tissue from all cases was retained with era-appropriate
consent. Cases included:
(i) Fourteen SUDEP from the Epilepsy Society Brain and Tissue
Bank (ESBTB) at UCL (collected between 2010 and 2015)
and from Brain UK via the pathology department at
Derriford Hospital, Plymouth (between 2007 and 2012).
These were further categorized into nine deﬁnite SUDEP
(complete and negative autopsy including toxicology), the
remaining ﬁve being probable or possible SUDEP (incom-
plete autopsy examination or competing cause of death
identiﬁed) (Nashef et al., 2012);
(ii) Seven cases with Dravet syndrome obtained from ESBTB
and the University of Melbourne Australia [as previously
reported (Catarino et al., 2011), between 1992 and 2010].
This group also included three SUDEP cases (two of
which were deﬁnite SUDEP);
(iii) Thirteen non-epilepsy controls were obtained through the
MRC Sudden Death Brain Bank, Edinburgh and ESBTB (be-
tween 2008 and 2015). These included 10 cases with sudden
death (non-neurological, non-epilepsy sudden death controls);
(iv) Six epilepsy controls without an epilepsy-related death
(1999–2015). The clinical and neuropathology records,
including epilepsy and drug history, chronicity, circum-
stances of death and main neuropathology ﬁndings are
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detailed in Supplementary Table 1 and summarized in
Table 1. Of note, in all epilepsy groups there were
cases with onset of seizures in the last 2 years of life
(3/14 in SUDEP, 1/7 in Dravet syndrome and 3/6 in epi-
lepsy controls) as well as cases with epilepsy duration of
410 years (8/14 in SUDEP, 5/7 in Dravet syndrome and
3/6 in epilepsy controls).
Tissue preparation
For all 40 cases, a single 5-mm thick medulla block was se-
lected. Where available, blocks were selected from the caudal
medulla (axial level between obex 0 and 12mm); in many cases
only one block of medulla was available for use. In seven cases,
only hemi-brainstems were used as the brainstem had been
divided sagittally as part of a protocol for 9.4T MRI brainstem
imaging (Patodia et al., in preparation) but all these cases
included the entire midline raphe nuclei. Serial sections were
cut through the block at 20-mm thickness using the Tissue-Tek
AutoSection automated microtome (Sakura Finetek) obtaining
150–200 sections per case. Every 10th section (equivalent to
200 mm steps) was stained for cresyl violet and obex levels
were conﬁrmed independently by two observers (M.T., S.P.)
using a standard atlas (Paxinos and Huang, 1995). A region
spanning 10 consecutive cresyl violet levels (equivalent to
2mm rostro-caudally) in each case was selected for further quan-
titative analysis, closest to the putative location of the pre-Bo¨tC
as based on human anatomical studies (Schwarzacher et al.,
2011). The mean mid-obex level for all cases was 6.5mm
(range 2–13mm) (Table 1) and there was no statistical difference
in mean mid-obex levels between the groups.
Immunohistochemistry and regions
of interest
Further adjacent sets of 10 interval sections, 200 mm apart,
were stained for SST, NK1R, TPH2 and serotonin transporter
(SERT). Single sections from the mid-obex region or each case
were double labelled for NK1R/SST and TPH2/SERT and two
sections from either end of the obex region under study were
stained for galanin. Immunohistochemistry and double label-
ling immunoﬂuorescence used standard staining protocols,
detailed in the Supplementary material and in Table 2. Two
regions of interest were selected for quantitation: (i) the VLM
quadrant was outlined geometrically on each section using co-
ordinates from clearly-deﬁned anatomical landmarks of the
inferior olive nuclei and the central recess of the fourth ven-
tricle (Fig. 1A). We considered this essential as the pre-Bo¨tC
does not have well deﬁned boundaries compared to other
brainstem nuclei (Schwarzacher et al., 2011) and this method
therefore ensured comparable capture in each case of the re-
ticular formation, including intermediate and lateral reticular
nuclei (Paxinos and Huang, 1995). (ii) The medullary raphe
region of interest extended from the fourth ventricle to the
olive ventrally and abutted the midline (Fig. 1A); this ensured
inclusion of serotonergic neurons in both raphe obscurus and
raphe pallidus (Benarroch, 2014).
Quantitative methods and image
analysis
All sections were analysed quantitatively and image analysis
appropriate for the staining pattern was carried out.
Stereology
In cresyl violet and SST sections, total neuronal number and
density were measured using the optical fractionator method
with a Zeiss microscope (Axioskop 2 mot Plus) 63 objective
oil emersion lens (aperture 1.4) and StereoInvestigator soft-
ware (Microbrightﬁeld Biosciences). A sampling fraction of
5% was selected for each region of interest for cresyl violet
and SST, using a counting box (100  100 mm and depth
10 mm) to keep the coefﬁcient of variation low (Gunderson
P5 0.01). Total neuronal counts in the whole rostro-caudal
Table 1 Summary of clinical details for the 40 cases in the four main groups studied
Group n Gender
M/F
Mean age onset
of epilepsy/mean
duration (years)
Mean age of
death, years
(range)
Mean brain
weighta, g
(range)
Mean
mid obex
level, mm
(range)
PMI/FT
mean
(days)
SUDEP
All (non-DS SUDEP) 14 8/6 13.6 /19 35.4 (18–53) 1399 (1310–1623) 6 (2–8) 3.2 /31
D-SUDEP 9 4/5 13.1 34.6 1365 7.3
P-SUDEP 5 4/1 14.6 36.8 1459 6.5
Dravet syndrome
ALL 7 4/3 0.8/18 18.7 (1–47) 1189 (1078–1340) 7 (4–13) 1.2/48
P-SUDEP 1 2/0 0.78 24 1151 10.5
D-SUDEP 2 1/0 0.6 11 1300 4
Non-epilepsy controls
All 13 10/3 NA 41.5 (23–80) 1469 (1374–1650) 6.5 (3.5–11.5) 3.4/15
NESD 10 8/2 NA 38.7 1469 6.8
Epilepsy controls 6 5/1 27/43 67 (47–84) 1307 (1185–1490) 8 (4–10.5) 2.3/50
Detailed case information is provided in Supplementary Table 1. From these four groups there were further subdivisions for definite SUDEP (D-SUDEP), possible or probable SUDEP
(P-SUDEP), and non-epilepsy sudden deaths (NESD).
aMean brain weights are given for the fresh weights; where the fresh weights were not available and only fixed weights 22 g was subtracted (based on previous study of brain weights
in SUDEP) (Thom et al., 2015). There was no significant difference in post-mortem interval between SUDEP epilepsy controls and non-epilepsy control groups.
DS = Dravet syndrome; FT = fixation times; NA = not applicable; PMI = post-mortem interval.
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region of interest were estimated. In addition, neuronal densi-
ties for each section (neurons/mm3) in each region of interest
were calculated relative to that obex level. In TPH2 sections, in
view of the low density of neurons in the VLM, a modiﬁed
method was used. Scanned images of the entire VLM region of
interest were imported into ImageJ (NIH, USA); all positive
cells were manually tagged and the cell density/area (mm2)
calculated.
Whole-slide scanning image analysis
Immunostained slides were scanned with a Leica SCN400F
digital slide scanner (Leica Microsystems) at 40 magniﬁca-
tion and analysed with Deﬁniens Tissue Studio software 3.6
(Deﬁniens AG, Munich, Germany) using the same region of
interest on both sides (Fig. 1A) and taking care to exclude any
artefacts or the edges of olivary nuclei. The intensity threshold
for positive labelling was set separately for each immunomar-
ker (Supplementary Fig. 1A); the total area of staining was
evaluated and expressed as a labelling index (percentage area
stained) for each region of interest, averaged over both left and
right sides for entire medulla sections. For SST, NK1R and
galanin labelling, a second analysis step was used in view of
the complex pattern of neuronal and ﬁbre network labelling,
providing two measures per case: labelling index (evaluating
all thresholded positive pixels) and ‘smoothed’ labelling index
(utilizing a Gaussian smoothing ﬁlter) (Supplementary Fig. 1B).
As for stereology, individual values for each section with re-
spect to the obex level were recorded in addition to the overall
value. Repeatability of measurements was tested with good
agreements.
Double labelling analysis
NK1R/SST and TPH2/SERT labelled slides were visualized
using a confocal scanning laser microscopy (LSM710; Zeiss)
and co-localization quantiﬁed with a Zeiss Axio Imager Z2
ﬂuorescent microscope (Supplementary material).
Statistical analysis and clinicopathol-
ogy correlations
Statistical analysis was carried out using SPSS version 22 (IBM
corporation, CA, USA) using Mann-Whitney, Kruskall-Wallis
and Spearman’s correlations for non-parametric data. Data
from the entire rostro-caudal region of interest were compared
between groups (SUDEP, deﬁnite SUDEP, Dravet syndrome,
epilepsy controls, non-epilepsy controls and non-epilepsy
sudden death controls) for statistical differences with P-values
of 50.05. In addition, differences between groups with respect
to obex levels (using values averaged over ﬁve increments: obex
1–2, 3–4, 5–6, 7–8 and 9–10mm) were evaluated to assess
patterns and variations across the rostro-caudal medulla). For
graphical representation of data, Graphpad Prism 7 (University
of California, San Diego) was used.
Results
Nissl staining
Neuronal cells of varying size, morphology and lipofuscin
content were present in the VLM in cresyl violet stained sec-
tions in all cases and included in the stereological analysis (Fig.
1B). Total neuronal numbers were not statistically signiﬁcant
differences between groups (Table 3). However, analysis of
mean neuronal densities at 2mm obex intervals showed sig-
niﬁcantly lower neuronal densities at obex 3–4mm in all
SUDEP cases compared with non-epilepsy controls
(P = 0.008) (Fig. 1C). There were no signiﬁcant differences
at other obex levels or between other groups (Fig. 1C).
Somatostatin
Medium-to-large neurons were labelled in the medulla with
SST, being mainly dispersed through the reticular forma-
tion (Bouras et al., 1987); there was no qualitative differ-
ence in labelling patterns between groups. In addition,
networks of SST-positive varicose or beaded ﬁbres and
terminals were prominent in the lateral reticular region
(Bouras et al., 1987); these were visualized as a fan-like
band of labelling at low power extending from the fourth
ventricle (Fig. 1D). Distinct neuronal types were noted with
SST in the VLM and were analysed separately: (i) neurons
with intense SST cytoplasmic labelling (SST-SOMA+)
(Fig. 1E and F); (ii) neurons surrounded by a peripheral
rim of synaptic labelling (SST-PERIPH+) (Fig. 1G and
H); and (iii) SST-negative neurons (Fig. 1E and F,
arrows). In addition, whole-slide scanning image analysis
(WSS) was used to quantify the overall labelling of cells
Table 2 Immunohistochemistry panel
Immunomarker Clone and source Dilution Region of
interest
Quantitative
method
Cresyl violet/Nissl - - VLM Stereology
Somatostatin (SST) Rb H-106, Santacruz Biotechnology 1:500 VLM Stereology, WSS
Neurokinin 1 receptor (NK1R) S8305, Sigma Aldrich 1:5000 VLM WSS
Galanin sc-166431, Santacruz Biotechnology 1:1000 VLM, MR WSS
Tryptophan hydroxylase (TPH2) AB121013, Abcam 1:1500; goat polyclonal VLM, MR Stereology, WSS
Serotonin transporter (SERT or 5HTT) MAB5618, Millipore 1:2500; mouse monoclonal VLM, MR WSS
TPH2/SERT MAB5618, Millipore 1:500/1:2000 VLM, MR IF, Zen
NK1R/SST MAB5618, Millipore 1:500/1:2000 VLM Qualitative evaluation only
These were used to assess the pre-Bo¨tzinger region and medullary raphe, and the quantitative methods used to assess each marker is indicated. IF = immunofluorescence co-
localization; MR = medullary raphe; WSS = whole-slide scanning image analysis.
1722 | BRAIN 2018: 141; 1719–1733 S. Patodia et al.
D
ow
nloaded from
 https://academ
ic.oup.com
/brain/article-abstract/141/6/1719/4955842 by guest on 06 Septem
ber 2019
Figure 1 Stereology analysis of neurons in VLM. (A) Cresyl violet (CV). The regions of interest were delineated using the image analysis systems
by drawing a rectangle in one-half of the brainstem (dashed red lines) using anatomical boundaries. The midline was first drawn and a parallel line at the
lateral edge of the inferior olive nucleus. Perpendicular lines to these were drawn through the ventral recess of the fourth ventricle and the ventromedial
part of the olive. The outer, ventral quadrant of this region (shown in yellow) became VLM, with the ventral aspect extended along the contour of the
olive. Care was taken to exclude the olive nucleus from all quantitative analysis. The medial raphe (MR) region of interest was the medial quarter of the
main rectangle (shown in orange), abutting the midline. This is shown for a hemi-brainstem, which was used in stereology. For whole slide scanning
analysis in whole brainstem sections, identical region of interest were constructed on the opposite side and mean values over the two sides calculated.
(B) Cresyl violet-stained neurons in the VLM/reticular formation (top); in the bottom image a neuron distended with lipofuscin is shown. (C) Line graphs
of neuronal densities on cresyl violet stain in the VLM plotted as mean values (error bars are standard deviations) in SUDEP and control groups relative
to the obex level (x-axis) at 2-mm intervals from 1 to 10 mm. There were significant differences between SUDEP and controls at obex 3–4 mm (asterisk).
(D) SST labelling in a hemi-medulla section with a band of staining fanning out from ventricle to lateral reticular regions (arrow); note also labelling in the
solitary nuclei. (E and F) Examples of patterns of SST labelling are shown with SST-SOMA+ neurons and diffuse cytoplasmic positivity (arrows indicate
unstained neurons); in G and H. SST-PERIPH+ neurons with peripheral synaptic like beads of positivity but negative cytoplasm are shown. (I) Bar graph
representing the fraction of total cells in VLM labelled with SST showing SST-SOMA+ and SST-PERIPH+ patterns in eight groups. SST-SOMA+ fractions
were not significantly different between groups but significantly lower SST-PERIPH+ cells were noted in SUDEP (Error bars represent standard deviations
for the groups; see Table 3 for significant differences in mean neuronal numbers (and standard deviations) between groups. (J) Line graph of variation of SST-
SOMA+ neurons with obex level in SUDEP and non-epilepsy sudden death controls expressed as ratio of total neuronal densities (error bars represent
standard deviations for the groups); the relative number of labelled cells increased with more rostral obex levels and the black dashed line shows values for
all cases which correlated with higher obex levels (P = 0.014). (K) Line graph of variations of SST-PERIPH+ neurons with obex level between non epilepsy
controls, non-epilepsy sudden death, SUDEP and definite-SUDEP expressed as neuronal density acquired from stereology data (mean values and error
bars are standard deviations). The density of neurons declines for all groups with rostral obex levels but is lower in the epilepsy groups compared to the
non-epilepsy controls at all obex levels, with the most significant differences noted between definite SUDEP and non-epilepsy sudden death controls at
obex 7–8mm (*P = 0.05). Magnifications: hemi-brainstem images taken at 0.58 and photomicrographs with 40 objective lens. Scale bar in A = 1.5 mm
for A and D, and 55 mm in B and E–H. D-SUDEP = definite SUDEP; NEC = non-epilepsy controls; NESD = non-epilepsy sudden death controls.
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and ﬁbres in the VLM. The rationale of this approach was
to distinguish SST-expressing neurons from SST synaptic
terminals and networks (that modulate neurons) in the
VLM.
SST SOMA+ -labelled neurons represented from 22%
(in non-epilepsy controls) to 26% (in Dravet syndrome)
of all VLM neurons between the groups (Fig. 1I); total
neuronal counts varied between groups but without signiﬁ-
cance (Table 3). SST-PERIPH+ neurons represented from
21% (in deﬁnite SUDEP) to 31% (in non-epilepsy sudden
death controls) of all neurons (Fig. 1I); total neuronal
counts were signiﬁcantly lower in SUDEP groups compared
to non-epilepsy controls and non-epilepsy sudden death
controls (P4 0.01) with less signiﬁcant reductions noted
for epilepsy controls and Dravet syndrome compared to
non-epilepsy controls (Table 3 and Fig. 1I) (P5 0.05
to 0.01). There was a signiﬁcant increase in the relative
proportion of SST-SOMA+ neurons with higher mid-obex
level for the region of interest (P = 0.014), in keeping
with previous reports (Schwarzacher et al., 2011)
(Fig. 1J). This trend was not seen for SST-PERIPH+ neu-
rons, which if anything declined in number in the rostral
obex (Fig. 1K). Further analysis of mean neuronal densities
at 2mm obex increments did not show signiﬁcant
differences for SST-SOMA+ neuronal densities between
SUDEP and control groups (Fig. 1J). For SST-PERIPH+ ,
lower densities were noted for all epilepsy groups
compared to non-epilepsy controls at all obex levels, with
greatest signiﬁcant at obex 7–8mm (deﬁnite SUDEP:
non-epilepsy sudden death controls) (P5 0.05) (Fig. 1K).
WSS analysis did not show signiﬁcant differences in label-
ling index between groups (Table 4) or in relation to obex
level.
Neurokinin 1 receptor
NK1R labelling highlighted a zone extending from the ﬂoor
of the fourth ventricle through the reticular formation in all
groups (Fig. 2A); this corresponded on higher magniﬁcation
to a plexus of processes with a mainly peri-membranous
labelling of neurons (Fig. 2B). It was not possible to clearly
discriminate positive from negative neurons and WSS was
used for quantitative analysis rather than stereology. Lower
mean NK1R labelling index (smoothed) was noted in all
SUDEP cases compared to non-epilepsy controls (P = 0.02)
and non-epilepsy sudden death controls (P = 0.046)
(Table 4 and Supplementary Fig. 2A). There was no
correlation between the NK1R labelling index and the
Table 3 Stereology counts on the VLM quadrant
Group classification CV SST SOMA + SST PERIPH + SST NEGATIVE TPH2a
Total
neurons (SD)
Total neurons (SD)a,b Total neurons (SD)a,b Total neurons (SD)a,b Neuronal
density
(106/mm2)
All SUDEP 80 530 (21 673) 17 759 (6161) 15 817 (5915) 35 834 (6782) 1.3 (0.4)
n = 17 P = 0.003 (NEC) n = 17
P = 0.01 (NESD)
n = 17
D-SUDEP 83 499 (23 124) 17 214 (5821) 14 750 (4666) 36 548 (7529) 1.4 (0.4)
n = 10 P = 0.01 (NESD) n = 10
n = 10
SUDEP (excluding
Dravet syndrome)
80 772 (22 709) 17 713 (6213) 15 424 (4325) 37 296 (5971) 1.4 (0.4)
n = 14 P = 0.003 (NEC) n = 14
n = 14
Dravet syndrome 68 567 (15 167) 17 406 (5282) 16 076 (8750) 30 319 (8403) 1.5 (0.8)
n = 6 P = 0.04 (NEC) n = 6
n = 6
EP-controls
(excluding Dravet
syndrome)
80 547 (18 647) 19 824 (3373) 18 253 (6056) 39 314 (9899) 1.4 (0.4)
n = 6 n = 6 n = 6
All epilepsy controls 76 095 (17 837) 18 687 (3883) 16 571 (6115) 37 389 (10 816) 1.7 (0.5)
n = 8 P = 0.01 (NEC) n = 8
n = 8
NEC 81 011 (17 191) 14 919 (8503) 20 677 (11 380) 31 803 (16 910) 2.1 (1.3)
n = 11 n = 11 n = 11
NESD 79 756 (19 107) 13 775 (8945) 18 988 (12 294) 28 068 (16 582) 2.0 (1.3)
n = 8 n = 8 n = 8
This is shown for the eight group categories with mean total neuronal counts (SD) for the region of interest (Fig. 1A) equivalent to 2 mm in rostro-caudal direction.
In SST sections, three neuronal cell types were counted, those with intense SST cytoplasmic labelling (SST-SOMA), neurons surrounded by a peripheral rim of synaptic labelling
(SST-PERIPH) and unlabelled neurons (Fig. 2).
an = cases available for this study.
bIn one Dravet syndrome case and two non-epilepsy sudden death cases of the study group of 40 the staining was suboptimal and data analysis not included. Statistical differences
shown in bold using the Mann-Whitney tests.
CV = cresyl violet; D-SUDEP = definite SUDEP; EP = epilepsy controls; NEC = non-epilepsy controls; NESD = non-epilepsy sudden death.
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mid-obex level of the region of interest. Further comparison
of mean labelling index in cases at 2mm obex intervals
between groups showed lower labelling index in SUDEP
compared to non-epilepsy controls at obex 3–4mm
(P = 0.04) (Fig. 2C).
NK1R:SST co-localization
Double labelling conﬁrmed previous observations
(Schwarzacher et al., 2011; Wei et al., 2012) with mixed
populations of double-labelled, single-labelled cells as
well as neurons with a peripheral pattern of SST labelling
Figure 2 Whole slide scanning analysis (NK1R and galanin). (A). NK1R at low power showing diffuse staining in the reticular formation
including a band extending into the lateral regions (arrowhead). (Bi and ii) At higher magnification complex networks and neuronal positivity with
NK1R is seen as peripheral labelling around neurons. (C) NK1R line graph of the labelling index (smoothed) in relation to obex level between SUDEP,
non-epilepsy sudden death controls (NESD) and epilepsy controls (mean values and standard deviation shown as error bars): there was no clear
increase in percentage labelling with obex and lowest labelling index were noted in the SUDEP groups with significant difference between the SUDEP
and non-epilepsy controls at obex 3–4 mm (P = 0.04). (D) NKR1 and SST double labelling in the VLM in different cases showing SST-SOMA+
(arrowhead), peripheral SST and NK1+ (double arrowhead) and double-labelled cells (arrow). (E) Galanin labelling at low magnification in a SUDEP
case showing a diffuse band of labelling extending through the VLM region (arrowhead) and distinct labelling is noted around the midline raphe nuclei
(arrow; shown at higher magnification in H). (F) Galanin in the VLM labelled scattered neurons but more prominent dense networks of processes
and fibres and surrounding individual neurons (G) in the VLM was noted. (H) Similar intense patterns of galanin labelling were noted in the medullary
raphe (MR) neuronal groups. (I) Bar graphs of galanin-labelling between group in the VLM and (J) in the medullary raphe showing significant reduction in
the VLM in the SUDEP cases. Magnifications: hemi-brainstem images taken at 0.58 and photomicrographs (B, C and G) with 40 and (F and H)
20 objective lens. Scale bar in A = 3 mm in A and D, 500 mm in H, 50 mm in B, D and G; and 100 mm in F. D-SUDEP = definite SUDEP; DS = Dravet
syndrome; EP = epilepsy controls; NEC = non-epilepsy controls.
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(Fig. 2D); consistent labelling was not achieved in all cases
and further quantitative evaluation of the series was not
carried out. However, we observed a strong correlation
between SST and NK1R labelling index on single-stained
sections (all cases P50.000, Supplementary Fig. 2B and C;
SUDEP alone P = 0.001 Supplementary Fig. 2D; epilepsy
controls P = 0.007; non-epilepsy controls P = 0.001). We
did not observe any relationship between the relative SST/
NKR1 labelling index and obex level.
Galanin
Labelling for galanin, both in the VLM and in the medul-
lary raphe regions, was prominent at low magniﬁcation in
all groups (Fig. 2E and H) mainly forming dense networks
of processes surrounding neurons, with scattered positive
neurons in the VLM (Fig. 2F) as well as some neurons
with prominent pericellular labelling (Fig. 2G). WSS ana-
lysis showed signiﬁcantly lower labelling index in VLM in
SUDEP compared to non-epilepsy controls (P = 0.002; for
total and smoothed labelling index) and for deﬁnite SUDEP
compared to non-epilepsy sudden death controls
(P50.007; for total and smoothed labelling index) but
not for other groups (Fig. 2I and Table 4). In the medullary
raphe, less signiﬁcant reductions in labelling index in
SUDEP compared to non-epilepsy controls (P = 0.035)
and deﬁnite SUDEP to non-epilepsy sudden death controls
were noted (P = 0.04) (Fig. 2J and Table 4). There was no
correlation between the galanin labelling index and obex
level.
Tryptophan hydroxylase
Positive neurons with TPH2 were prominent in medullary
raphe nuclei (corresponding to the raphe magnus, obscurus
and pallidus), forming dense aggregates (Fig. 3A); a similar
distribution was noted in all groups. Scattered positive cells
were also present through the reticular formation and VLM
region (Fig. 3B), in keeping with previous descriptions
(Paxinos and Huang, 1995; Tada et al., 2009; Benarroch,
2014). Immuno-labelling was primarily in the neuronal
soma, extending into proximal processes, with rarer long
traversing processes (Fig. 3C). In the VLM, occasional neu-
rons were noted with accentuated peripheral labelling
(Fig. 3C, inset). TPH2-positive neurons were also noted in
the arcuate nuclei, single cells along the sub-pial border of
the lateral medulla, and occasionally in the ﬂoor of the
fourth ventricle and near the dorsal vagal nuclei.
TPH2 cell densities varied between groups but were not
signiﬁcantly different (Table 3) and there was no correl-
ation between TPH2 cell counts and obex level.
Comparison of mean TPH2 cell counts in the VLM at
2mm obex intervals between groups were lower for the
SUDEP and epilepsy controls than non-epilepsy controls
at all levels, with statistical difference noted between all
epilepsy cases and controls at obex 9–10mm (P = 0.034)
(Fig. 3E).
The TPH2 labelling index was consistently higher in the
medullary raphe than VLM in all groups (Table 4). The
TPH2 labelling index in the VLM was signiﬁcantly lower in
SUDEP and deﬁnite SUDEP groups than non-epilepsy
Table 4 Whole slide scanning analysis in VLM and medial raphe with mean values shown for all eight groups
SST NK1R Galanin TPH2 SERT
Group
classification
VLM VLM
(smootheda)
VLM VLM
(smootheda)
VLM
(smootheda)
MR
(smootheda)
VLM MR VLM MR
All SUDEP 6.2 (1.4) 2.4 (0.9) 8 (1.7) 1.5 (0.6) 53.3 (18) 54.4 (18) 0.7 (0.7) 1.7 (2) 27.9 (14) 40.4 (13)
n = 17 n = 17 n = 17 n = 17 n = 15 n = 15 n = 17 n = 17 n = 17 n = 17
D-SUDEP 6.3 (1.7) 2.6 (1.2) 8.2 (1.8) 1.6 (0.8) 48.6 (19) 51 (20) 0.5 (0.3) 1.1 (0.9) 34.9 (13) 36.4 (9)
n = 10 n = 10 n = 10 n = 10 n = 10 n = 10 n = 10 n = 10 n = 10 n = 10
SUDEP
(excluding
DS)
6.2 (1.6) 2.6 (1) 7.7 (1.7) 1.6 (0.7) 49.7 (17) 52.7 (19) 0.7 (0.7) 1.6 (1.7) 38.1 (13) 39.5 (11)
n = 14 n = 14 n = 14 n = 14 n = 12 n = 12 n = 14 n = 14 n = 14 n = 14
Dravet
syndrome
6.1 (0.9) 2.1 (0.4) 8.9 (0.9) 1.3 (0.4) 60.6 (18) 56.8 (17) 1.3 (1.3) 2.4 (3.7) 41.2 (18) 47.9 (16.7)
n = 7 n = 7 n = 5 n = 5 n = 6 n = 6 n = 7 n = 7 n = 7 n = 7
EP-controls
(excluding
DS)
5.2 (0.8) 2.1 (0.5) 7.7 (0.6) 1.8 (0.4) 53.2 (29) 50.6 (26) 1.8 (2.1) 1.9 (1.0) 40 (10) 42.7 (10)
n = 6 n = 6 n = 6 n = 6 n = 6 n = 6 n = 6 n = 6 n = 6 n = 6
All epilepsy
controls
5.6 (1.1) 2.3 (0.5) 7.9 (0.6) 1.7 (0.4) 56.5 (25.6) 54.4 (23) 1.5 (1.9) 1.7 (0.9) 42 (12) 45.3 (10.8)
n = 8 n = 8 n = 8 n = 8 n = 8 n = 8 n = 8 n = 8 n = 8 n = 8
NEC 5.7 (0.9) 2.7 (1) 7.7 (2) 2.2 (1) 68.9 (9.5) 67.3 (8.7) 2.9 (3.4) 5.7 (7.8) 43.5 (20) 52.8 (11)
n = 12 n = 12 n = 13 n = 13 n = 10 n = 10 n = 12 n = 12 n = 13 N = 11
NESD 5.5 (0.8) 2.3 (0.3) 7.2 (2) 1.9 (0.5) 67.4 (8.7) 65.6 (7) 2.0 (1.1) 3.5 (2.1) 42 (23) 51.9 (12)
n = 10 n = 10 n = 10 n = 10 n = 9 n = 9 n = 9 n = 9 n = 10 n = 8
All obex levels are included in this analysis. All values are shown as labelling index [shown as percentage of area with immunostaining (i.e. range 0–100)].
n = the number of cases studied in each group with each marker (in occasional cases with each marker the section staining failed quality control).
a‘Smoothed’ data refers to additional Gaussian filters used on Definiens image analysis (see ‘Materials and methods’ section); for Galanin only the smoothed data is shown but both
total and smoothed data showed significant differences between SUDEP and controls (see ‘Results’ section). Significant results highlighted in bold between SUDEP and controls
(see ‘Results’ section). See also Supplementary Fig. 1 for graphs. Values in bold represent data with significant differences between SUDEP and control groups.
DS = Dravet syndrome; EP = epilepsy controls; MR = medial raphe; NEC = non-epilepsy controls; NESD = non-epilepsy sudden death controls.
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control groups (both non-epilepsy controls and non-epi-
lepsy sudden death controls) (P5 0.005); no signiﬁcant
differences were noted between Dravet syndrome and epi-
lepsy controls compared to non-epilepsy control groups
(Table 4 and Fig. 3D). For the medullary raphe, a similar
reduction was noted in SUDEP groups compared to non-
epilepsy controls but with less statistical signiﬁcance than
the VLM (P50.01) (Table 4). There was a positive
correlation between the labelling index in the medullary
raphe and higher obex level (P = 0.01) but not for VLM;
the higher labelling index in the medullary raphe compared
to VLM was most apparent between obex 3mm to 10mm
(Fig. 3F). Further comparison of mean labelling index at
2mm obex intervals between the groups showed lower
labelling index in SUDEP (and deﬁnite SUDEP) than non-
epilepsy controls (and non-epilepsy sudden death controls)
with greatest signiﬁcance observed in the VLM at obex
3–4mm and 7–8mm (P50.05) (Fig. 3F).
Serotonin transporter
SERT immunolabelling in both the medullary raphe and
VLM region consisted of a dense plexus, mainly surrounding
neuronal soma and dendrites, although distinct cytoplasmic
labelling of some neurons was also noted and observed in all
groups (Fig. 4A and B). SERT labelling index was overall
higher in the medullary raphe than VLM across all groups
(Table 4). Lower SERT labelling index in the medullary
raphe was noted in SUDEP than in non-epilepsy controls
(P = 0.014) and in deﬁnite SUDEP than in non-epilepsy
sudden death controls (P = 0.016) (Fig. 4C). There were no
signiﬁcant differences between the other groups in the me-
dullary raphe or in the VLM for any groups. There was no
signiﬁcant correlation of SERT labelling index with obex
level. Comparisons of the labelling index between groups
at 2mm obex intervals showed lower values in SUDEP,
with greatest signiﬁcance in the medullary raphe between
SUDEP and non-epilepsy controls at obex 7–8mm
(P = 0.024) and in the VLM at obex 3–4mm (P = 0.042).
TPH2/SERT co-localization
Double labelling for SERT/TPH2 showed some regional
overlap in the distribution of labelling in the medullary
raphe and VLM observed in all cases. SERT showed more
extensive networks around processes and peripheral labelling
of TPH2-positive as well as around unlabelled cells (Fig. 4D
and F). In addition, several neurons in these regions showed
cytoplasmic double labelling (Fig. 4D and E). Quantitative
Figure 3 Serotonergic neurons. (A) Tryptophan hydroxylase (TPH2) labelling in the median raphe showing distinct neuronal labelling and
processes. (B) In the VLM, reduced density of neurons were noted (inset cluster of neurons in the floor of the fourth ventricle were occasionally
also noted). (C) TPH2-positive neurons and coarse dendrites in VLM with occasional fine axon crossing in the background (arrow). Inset: TPH2
positive neurons in VLM with more peripheral labelling pattern was occasionally noted. (D) Bar chart showing the differences in labelling index
between the groups in the VLM, which was significantly lower in SUDEP groups than non-epilepsy controls. (E) Line graph of mean TPH2 cell
counts between groups (mean values and standard deviation show as error bars) in the VLM with obex intervals were lower for the SUDEP and
epilepsy controls than non-epilepsy controls (NEC) at all levels, with the greatest statistical difference noted between all epilepsy cases and
controls at obex 9–10 mm (P = 0.034). (F) Line graph of TPH2 labelling in medullary raphe and VLM (shown as dashed lines and single lines,
respectively) of mean values (and error bars representing standard deviations) with respect to obex levels for definite SUDEP and non-epilepsy
sudden death controls (NESD). A positive correlation of medullary raphe labelling index with more rostral obex levels (P = 0.01) was noted and
lower labelling index in SUDEP than NESD. Magnifications: photomicrographs with 10 (A), 20 (B) and 40 objective lenses. Scale bar in
A = 300 mm in A, 200 mm in B, and 90 mm in C.
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evaluation of the relative areas of co-localization was higher
in non-epilepsy controls than SUDEP or epilepsy controls in
both VLM and medullary raphe but were not signiﬁcantly
different. Co-localization was signiﬁcantly higher in medul-
lary raphe than VLM in all groups, which may merely reﬂect
anatomical differences in serotonergic cell populations; how-
ever, greater differences were noted between these regions for
SUDEP (P = 0.001) compared to epilepsy controls (P = 0.05)
and non-epilepsy controls (P = 0.01). There was a signiﬁcant
positive correlation between co-localization and higher obex
level for all cases for the medullary raphe (P = 0.009), but
between groups signiﬁcant correlations were noted only for
the SUDEP group (VLM, P = 0.006 and medullary raphe,
P5 0.000) (Supplementary Fig. 3A).
Clinical–pathology correlations
In cresyl violet sections, there was a positive correlation
between VLM neuronal density and duration of epilepsy
(P5 0.01) and a trend for higher TPH2 neuronal counts
in epilepsy patients with epilepsy duration of 410 years
compared to cases with epilepsy onset 52 years
(P4 0.05, Supplementary Fig. 3B). Higher SST and
NK1R labelling index was also noted in cases with epi-
lepsy chronicity of 410 years, particularly the epilepsy
control group (P4 0.025, Supplementary Fig. 2E and F).
There was no relationship between any quantiﬁed meas-
ures and gender. A positive association with the NK1R
labelling index and age at death was noted (P5 0.01)
and for TPH2, signiﬁcant positive correlations were
noted between age at death and labelling index in both
VLM (P5 0.01) and medullary raphe (P50.005)
(Supplementary Fig. 3C and D). We did not have complete
drug histories in all cases (Supplementary Table 1), but
only one person, in the control group, had been prescribed
a selective serotonin re-uptake inhibitor (Case 27); SERT
and TPH2 values in this case were in the middle range.
There was variation in ﬁxation times between cases col-
lected from different centres (Table 1); we did not observe
a signiﬁcant correlation between labelling index or cell
Figure 4 SERT and co-localization studies. (A) SERT labelling in the medial raphe (MR) and (B) VLM showed dense synaptic plexus of
labelling mainly around neurons and processes. In addition strong cytoplasmic labelling of neuronal cells in both regions was also noted
(arrowheads). (C) Bar chart of the mean labelling indices between groups in the medullary raphe with significant differences noted between
SUDEP cases and non-epilepsy control groups. (D–F) Double labelled immunofluorescence of SERT with TPH2. There was strong regional
expression of both markers concentrating in similar areas in the VLM (D and F) and medullary raphe (E). In the VLM, labelling of SERT around
TPH2-negative neurons was evident (arrows) as well as SERT labelling at the periphery of TPH2 positive neurons (F) as well as processes
(dendrites/axons; arrowhead in D). In addition, in both medullary raphe and VLM, co-localization of labelling in the cell was noted (chevrons in
F and E). D-SUDEP = definite SUDEP; DS = Dravet syndrome; NEC = non-epilepsy controls; NESD = non-epilepsy sudden death controls.
Magnifications: photomicrographs with 40 objective for (A and B). Scale bar in A = 230 mm in A, B and D, 300 mm in E and 80 mm in F.
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counts in the VLM and ﬁxation time or relationship with
post-mortem intervals.
Discussion
There is strong clinical and experimental evidence for cen-
trally-mediated ictal respiratory dysfunction or central
apnoea as a pathomechanism in SUDEP (Ryvlin et al.,
2013; Sowers et al., 2013; Kennedy and Seyal, 2015).
MRI studies indicate structural abnormalities in the brain-
stem autonomic regions in SUDEP although the patho-
logical basis is unknown (Mueller et al., 2014). In a
series of SUDEP post-mortem cases we have shown signiﬁ-
cant alterations in the VLM (which includes the putative
human pre-Bo¨tC region) and, to a lesser degree, in the me-
dullary raphe regions of the medulla. These involved NK1R
and SST neuronal populations of the VLM. We also noted
signiﬁcant reductions in medullary neuromodulatory sys-
tems, including serotoninergic and galaninergic networks.
There was also some evidence for an association of neuro-
pathological alterations with duration of seizures. These
ﬁndings could indicate epilepsy-mediated pathology in
medullary respiratory neuronal groups that act as a vulner-
ability factor for SUDEP.
SST/NK1R neuronal alterations in
VLM in SUDEP
NKR1 and SST neurons in the human VLM include the
putative pre-Bo¨tC, present bilaterally as an ill-deﬁned dif-
fuse nucleus, located near the lateral reticular and nucleus
ambiguus within the intermediate reticular zone (Huang
and Paxinos, 1995). Neurons of varied sizes are seen on cre-
syl violet stain (Paxinos and Huang, 1995; Schwarzacher
et al., 2011) corresponding to the mixed excitatory and
inhibitory neurons in addition to the presumed ‘rythmo-
genic’ pacemaker subsets of NK1R/SST neurons (Bouras
et al., 1987; Stornetta et al., 2003; Schwarzacher et al.,
2011; Ikeda et al., 2017); from animal studies these
neurons form the essential circuits that coordinate and
automate inspiration (Wei et al., 2012).
We noted a reduction of SST-positive neurons in the
VLM speciﬁcally in SUDEP as well as a reduction of
NK1R labelling, which could suggest deﬁcient inspiratory
networks. Alterations in pre-Bo¨tC NK1R and SST
neurons has been previously reported in SIDS (Lavezzi
and Matturri, 2008) and neurodegenerative diseases such
as multiple system atrophy (Schwarzacher et al., 2011) and
Parkinson’s disease associated with disordered breathing
(Presti et al., 2014). SST is an inhibitory neuromodulator
of respiration; experimental silencing of SST neurons in the
pre-Bo¨tC induces apnoea (Cui et al., 2016) and blocking of
SST receptors prevents auto-resuscitation from asphyxia
(Ramirez-Jarquin et al., 2012). Slow, selective ablation of
NK1R neurons results in apnoeic episodes that ﬁrst occur
during sleep, before ataxic breathing in wakefulness
(McKay et al., 2005). This implies that signiﬁcant loss of
pre-Bo¨tC neurons is required before pathological breathing
occurs, but that the ﬁrst manifestations, associated with
milder loss occur during sleep (Feldman and Del Negro,
2006), which is of potential relevance to the predominance
of nocturnal SUDEP cases.
Animal studies support that there is not complete overlap
of expression of SST and NK1R in the pre-Bo¨tC: different
neuronal subsets are present that likely reﬂect diverging
physiological functions (Wei et al., 2012; Koshiya et al.,
2014). Furthermore, not all neurons of a single immuno-
phenotype share similar functions, for example not all
NK1R+ neurons are ‘pacemaker’ cells (Ikeda et al.,
2017). NK1R+ /SST-SOMA+, NK1R+ /SST-PERIPH+ neu-
rons (with peri-somatic SST GABAergic/inhibitory synaptic
terminals) as well as NK1R+ /SST and NK1R/SST+ neu-
rons have been described (Wei et al., 2012), as have
neurons negative for both markers. In the rodent, it is
estimated that 15% of the 3000 pre-Bo¨tC neurons are
SST-expressing (Cui et al., 2016). These reports compare
with our ﬁndings where 20–26% of VLM neurons were
SST-SOMA+, and a further 21–31% were SST-PERIPH+ ,
a proportion showed NK1R+ /SST+ double-labelling and a
strong correlation between overall NK1R and SST labelling
was observed. In addition to a reduction of NK1R labelling
in SUDEP, we noted speciﬁc alterations in SST neuronal
populations, with a reduction in SST-PERIPH+ , but not
SST-SOMA+ cells or overall SST labelling. Animal studies
supports that GABAergic SST+ terminals synapsing onto
pre-Bo¨tC neurons arise from other brainstem nuclei, includ-
ing the solitary tract nucleus and parabrachial nucleus
(Epelbaum et al., 1994; Cui et al., 2016) primarily modu-
lating respiratory activity (Cui et al., 2016). Our ﬁndings
could therefore be interpreted as loss of neuromodulatory
SST input rather than a primary loss of SST VLM
pacemaker neurons, a hypothesis that requires validation
through further studies of other brainstem regions
(Supplementary Fig. 4).
Rostro-caudal distribution of NK1R
and SST
Our archival cases extended over a range of obex levels
and, although not different between the groups, it was im-
portant to factor in any pathological differences in relation
to rostro-caudal level. Our current understanding of the
connectivity and relationship of the pre-Bo¨tC with other
medullary respiratory nuclear columns is based largely on
animal data (reviewed in Smith et al., 2013; Koshiya et al.,
2014; Ikeda et al., 2017). Functional imaging studies of the
respiratory control network in humans as yet lack the spa-
tial resolution to distinguish individual nuclear groups
(Pattinson et al., 2009). In animals, there is a hierarchical
organization of nuclei in a rostro-caudal direction; the
Bo¨tzinger complex lies rostral to the pre-Bo¨tC, exerting
expiratory and inspiratory respiratory rhythms,
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respectively. Both of these nuclei are more rostral than ven-
tral respiratory groups that coordinate output to the phre-
nic and spinal motor neurons (Smith et al., 2013; Ikeda
et al., 2017). One seminal study on the human brain loca-
lized the axial level of the human homologue of the pre-
Bo¨tC, based on the density of SST/NK1R neurons, between
obex 6 to 14mm and maximal at obex 9mm; this was
supported by a peak in cresyl violet neuronal densities in
this region at 9mm (Schwarzacher et al., 2011). Our study,
which used stereology rather than cell counting, did not
show a signiﬁcant variation in cresyl violet neurons in the
VLM with obex level. The likely explanation for this dif-
ference is methodological, in that the region of interest we
chose included the entire ventrolateral quadrant of the me-
dulla whereas in Schwarzacher’s study the area analysed
was limited to a region between the ambiguus nucleus,
trigeminal tract and the inferior olive (Schwarzacher
et al., 2011). Other human pathology studies of pre-Bo¨tC
neurons have either not deﬁned their region of interest,
used different cell counting methods or the obex level
was not detailed, which precludes a meaningful comparison
of data (Lavezzi and Matturri, 2008; Tada et al., 2009;
Presti et al., 2014). Our ﬁndings of an increase in the rela-
tive proportion of SST-SOMA+ cells with higher obex level
(obex 9–10mm), particularly noted in controls groups,
does align with Schwarzacher’s localization of the human
pre-Bo¨tC (Schwarzacher et al., 2011). Furthermore, the re-
duction in SST-PERIPH+ densities in SUDEP reached great-
est signiﬁcance at obex 7–8mm, which may be of
functional signiﬁcance to inspiratory networks in the puta-
tive human pre-Bo¨tC region. The lower neuronal densities
on cresyl violet and NK1R labelling in the more rostral
medulla (obex 3–4mm) in SUDEP cases could implicate
pathology in more caudal ventral respiratory groups regu-
lating motor control of respiration of equal functional im-
portance, which requires further investigation.
Galanergic medullary systems and
relevance in SUDEP
We studied the distribution of galanin, a bioactive peptide
shown to modulate brainstem serotonergic and noradrener-
gic systems in experimental models (Medel-Matus et al.,
2017) and observed reduced labelling in the SUDEP
groups. Galanergic neurons in the rodent medulla are con-
centrated in the nucleus of the solitary tract, VLM, retro-
trapezoid nucleus (Bochorishvili et al., 2012; Spirovski
et al., 2012) and locus coeruleus (Spirovski et al., 2012).
In the human brainstem we noted that galanin primarily
highlighted dense medullary networks, surrounding neu-
rons but with scattered positive neurons in the VLM, in
support of some local expression. The retrotrapezoid nu-
cleus in animals, critical for central respiratory chemorecep-
tion, has glutamatergic and galanergic neurons that synapse
with NK1R+ neurons of the pre-Bo¨tC and are considered
to activate breathing (Bochorishvili et al., 2012); local
galanin-expressing NK1R+ neurons in the VLM are also
activated following hypoxia and hypercapnia (Spirovski
et al., 2012). Other experimental studies have reported
that micro-injection of galanin into the pre-Bo¨tC exerts a
central respiratory depression (Abbott et al., 2009) and
galanin also mediates inhibition of serotonergic transmis-
sion in the medullary raphe (Medel-Matus et al., 2017).
Interestingly, rodent anatomical studies indicate differential
sources of galanergic input to speciﬁc medullary regions;
for example, there is no projection from the retrotrapezoid
galanergic neurons to the medullary raphe (Bochorishvili
et al., 2012). Our ﬁnding of signiﬁcantly reduced galanin
labelling in the VLM, but not the medullary raphe, in
SUDEP may be of physiological and functional relevance
and warrants further in-depth investigation of human gala-
nergic brainstem systems (Supplementary Fig. 4) and any
potential inﬂuences on respiratory networks in SUDEP.
Alterations in medullary serotonergic
systems in SUDEP
The pre-Bo¨tC is further modulated by serotonergic neurons
of the medulla, some of which have chemosensory proper-
ties, provide excitatory drive in conditions of hypercapnia
(as reviewed in Richerson, 2004) and are mediated by sev-
eral 5HT receptor subtypes (Richter et al., 2003). We used
labelling for TPH2, the main synthesising enzyme of 5-HT,
and labelling for its presynaptic transporter (SERT) and
found evidence for a reduction in the medullary serotoner-
gic systems in SUDEP, with preferential loss of TPH2 label-
ling in the VLM and SERT in the medullary raphe. For
TPH2 and SERT, the changes in SUDEP were maximal
at higher obex levels (7–10mm) near the putative axial
level of the human homologue of the pre-Bo¨tC. In addition,
co-localization of the cellular labelling of SERT and TPH2
was more signiﬁcantly reduced in the VLM compared to
medullary raphe in the SUDEP group. In all, these ﬁndings
indicate loss of serotonergic neuronal synthesizing capacity,
modiﬁed cellular re-uptake mechanisms which would result
in impaired delivery of 5HT, preferentially affecting the
pre-Bo¨tC region (Supplementary Fig. 4). In SUDEP, this
may functionally translate as compromised auto-resuscita-
tive responses during post-ictal hyperpcapnia.
Dysfunction of the brainstem serotonergic system in
SUDEP has been proposed as a central mechanism, through
effects on both ictal arousal and respiration (as reviewed in
Richerson, 2013; Sowers et al., 2013; Richerson et al.,
2016). For example, administration of serotonergic agents
rescued DBA/1 mice with susceptibility to seizure-induced
respiratory arrest and death (Faingold et al., 2016) and
both decreased ﬁring (Zhan et al., 2016) and activation
(Kommajosyula et al., 2017) of raphe neurons occurred
following seizures. In human studies, there is a considerable
literature on defective medullary serotonergic neurotrans-
mission in SIDS. Reduced 5-HT1A receptor binding in the
medulla and higher densities of 5HT neurons in the
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medullary raphe and ventral surface were shown in SIDS
but with lower 5-HTT (SERT) binding per neuron
(Paterson et al., 2006). We were unable to obtain reliable
staining for 5-HT receptors in ﬁxed post-mortem tissues.
Possible explanations for reduced TPH2 labelling in
SUDEP, compared to the ﬁndings in SIDS, could include
methodological differences but also maturational effects. In
our series, of mainly adults, we noted increased TPH2
labelling with age. Maturation changes to 5-HT neuronal
populations have been described in infancy (Kinney et al.,
2011) and, furthermore in SIDS, the majority of TPH2
medullary neurons were small, immature types (Paterson
et al., 2006; Kinney et al., 2011) compared to the large
fusiform and multipolar neurons in our adult series. This
highlights difﬁculties in the direct comparison of SIDS to
SUDEP cohorts. Nevertheless, in both studies there was
evidence for regional reduction in SERT labelling on
TPH2 medullary neurons, which indicates a potentially
common mechanism of re-uptake failure. In neurodegenera-
tive post-mortem studies, reduction of serotonergic neurons
has also been observed; loss of medullary raphe TPH2
neurons has been shown in multiple system atrophy and
in Parkinson’s disease with Lewy bodies and proposed as
relevant to the sleep-related disordered breathing occurring
in these conditions (Presti et al., 2014). Furthermore, in a
study of 12 patients with multiple system atrophy, signiﬁ-
cant reduction of TPH2 neurons was shown in both the
VLM and medullary raphe in those dying suddenly (Tada
et al., 2009).
Clinical correlations and seizure
effects on medullary neurons
The medullary neuronal changes we noted in the VLM and
medullary raphe may represent acute and chronic sequelae
of previous seizures. There are few pathology studies to
date of the brainstem in SUDEP; in a recent study from
our group, no signiﬁcant differences in acute inﬂammatory
changes in the medulla or evidence for blood–brain barrier
dysfunction was observed in SUDEP compared to controls
in several functionally different regions (Michalak et al.,
2017). There is evidence from experimental studies that
seizures and ictal electrophysiological changes extend to
medullary respiratory nuclei (Aiba and Noebels, 2015;
Kommajosyula et al., 2017; Villiere et al., 2017) and
could conceivably induce chronic cytopathological changes,
similar to that reported in remote cortical regions, thalamus
and cerebellum in human post-mortem studies (Crooks
et al., 2000; Blanc et al., 2011; Sinjab et al., 2013).
Although we did not ﬁnd deﬁnitive evidence for overall
neuronal loss in the VLM in SUDEP, we did note
increased cresyl violet and THP2 neuronal numbers with
a longer duration of seizures. Brainstem volume loss has
been observed in in vivo MRI studies (Mueller et al.,
2014); any independent effect of volume changes on rela-
tive neuronal density in SUDEP requires evaluation
through MRI-pathology correlative studies, which are
currently in progress. There was also a trend for increased
labelling with SST and NK1R in patients with epilepsy
duration of a decade or more suggesting adaptive modu-
lation of these systems can occur. There is a large
literature regarding modulation of inhibitory neurons in
temporal lobe epilepsy, including acquired channelopa-
thies (Bernard et al., 2004) and altered neuropeptidergic
systems (de Lanerolle et al., 2012) proposed to rep-
resent compensatory anti-epileptogenic mechanisms.
Nevertheless, our key ﬁnding in SUDEP was of a regional
reduction of medullary SST, NK1R as well as serotonergic
and galanergic labelling compared to controls. We specu-
late this could reﬂect immediate consumption following a
recent seizure prior to death (Ryvlin et al., 2013) or accu-
mulative depletion from recent poor seizure control (Chen
et al., 2017). Experimental models have shown an acute
reduction of NK1R labelled neurons in the pre-Bo¨tC in the
ventral respiratory column at 10 days following seizures
(Totola et al., 2017). Furthermore, in status epilepticus,
depletion or ‘neurochemical exhaustion’ of reserves
of neuropeptides, galanin and SST, and an increase in
neurokinin and endocytosis of receptors, is recognized
(Chen et al., 2007).
In this current study, we also included a series of Dravet
syndrome cases as this syndrome is associated with a higher
risk of SUDEP. Dravet syndrome is considered primarily a
dysfunction of GABAergic interneurons (Cheah et al.,
2012) and experimental studies do not yet support a pri-
mary respiratory dysfunction (Kalume, 2013). Although no
distinct differences were noted compared to other groups in
our study, this may relate to the small group size as well as
their genetic heterogeneity.
Limitations
In many cases only single blocks from variable obex levels
were available, taken as part of the diagnostic evaluation at
post-mortem examination. Furthermore, only selected
neurochemical markers were examined in a limited subset
of nuclei, all of which were involved in control of breath-
ing. Because of this restricted focus, we are unable to de-
ﬁnitively conclude that these abnormalities were the cause
of SUDEP, or that SUDEP causes selective changes in these
nuclei. Further studies are needed to determine whether
there are much more widespread abnormalities throughout
non-respiratory brainstem nuclei, and whether they are
involved in the pathophysiology of these deaths. Ideally
future brainstem studies in SUDEP should be conducted
in prospectively sampled and clinically/genetically stratiﬁed
SUDEP series with similar drug histories, ideally with fresh
tissue samples. We also identiﬁed that some alterations
were spatially restricted in the rostro-caudal axis; many
of the differences that were detected were relatively small
and may not be enough to cause a change in function
severe enough to cause death. Future systematic bio-bank-
ing in SUDEP with standardized brainstem sampling will
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enable larger case series on aligned obex levels to further
explore any rostro-caudal vulnerability of neurons system-
atically and their potential functional implications. Finally,
the post-mortem intervals and ﬁxation times varied
between cases in our series as they were collected from
various centres and brain banks in the UK. We did not
ﬁnd differences in staining in relation to these tissue pro-
cessing times in this small series and our ﬁndings of relative
differences in immunostaining between groups in different
regions of interest also argue against this as having a major
effect. Nevertheless, systematic biobanking in the future
could overcome these potential confounding factors from
variations in tissue collection and processing (Thom et al.,
2018).
Conclusion
To summarize, we have demonstrated alterations in neur-
onal populations in the pre-Bo¨tC region of the medulla in
SUDEP, with evidence for more signiﬁcant alterations in
neuromodulatory medullary neuropeptidergic and monoa-
minergic systems, including galanin, SST and serotonin.
Variations noted with obex level could be relevant to dif-
ferential effects within the rostro-caudal organization of
respiratory nuclear groups, which requires further investi-
gation. These alterations may represent a sequel of previous
seizures and a pathological risk factor for SUDEP through
defective respiratory homeostasis.
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